4.01 pm | 13 Feb 2012 |  Source: Moneycontrol.com

Dolat Capital is bullish on Dishman Pharma and has recommended accumulate rating on the stock with a target of Rs 64 in its February 10, 2012 research...

6.04 pm | 09 Feb 2012 |  Source: CNBC-TV18

SP Tulsian, sptulsian.com is negative on tyre stocks. ...

4.46 pm | 09 Feb 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, SP Tulsian of sptulsian.com analyses select stocks such as Gati, Dishman Pharma, Apollo Tyres, Dhanlaxmi Bank, infrastru...

2.50 pm | 09 Feb 2012 |  Source: CNBC-TV18

Managing director of Dishman Pharma tells CNBC-TV18 that higher earnings from its contract revenue business is what led to the surge in third quarter ...

2.44 pm | 19 Jan 2012 |  Source: CNBC-TV18

Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chie...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

6.20 pm | 11 Jan 2012 |  Source: Moneycontrol.com

KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

3.40 pm | 21 Nov 2011 |  Source: Moneycontrol.com

Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 68 in its November 16, 2011 ...

4.05 pm | 17 Nov 2011 |  Source: CNBC-TV18

Managing director of Dishman Pharmaceuticals, JR Vyas expects the topline growth to be 15% or even more going forward. He also added that the bottomli...

4.00 pm | 15 Oct 2011 |  Source: Moneycontrol.com

KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman Phar...

11.46 am | 11 Oct 2011 |  Source: Moneycontrol.com

Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dishman S...